Helix BioPharma's market cap is currently C$117.91M. The company's EPS TTM is C$-0.029; its P/E ratio is ―; Helix BioPharma is scheduled to report earnings on June 16, 2025, and the estimated EPS forecast is C$―. See an overview of income statement, balance sheet, and cash flow financials.
